Diabetes

Top Story

Once-weekly exenatide reduces MACE risk in patients with type 2 diabetes, CVD

Once-weekly exenatide reduces MACE risk in patients with type 2 diabetes, CVD
July 18, 2019
Meeting NewsVideo

VIDEO: Heart in Diabetes aims to address ‘avalanche of data’ on diabetes, CVD

July 16, 2019
PHILADELPHIA — In this video exclusive, Mikhail N. Kosiborod, MD, FACC, FAHA, co-chair of the third annual Heart in Diabetes conference, highlights recent…
Meeting News

Trial data highlight need for redefined guidelines for older adults with diabetes

July 15, 2019
PHILADELPHIA — Older adults with type 2 diabetes can derive meaningful cardiovascular and renal benefits from newer antihyperglycemic agents, and data from several…
Meeting News

Ethnicity, age, sex influence CV risk in type 2 diabetes

July 15, 2019
PHILADELPHIA — The growing global burden of type 2 diabetes and cardiovascular disease disproportionately affects people living in countries experiencing large…
More Headlines »
CME ABIM MOC

PCSK9 Inhibitors in Patients With Diabetes: A Closer Look at CV Risk Reduction

This activity is supported by an educational grant from Amgen.

There is an association between atherosclerotic cardiovascular disease and low-density lipoprotein cholesterol as well…
More »
Video
Meeting News

VIDEO: ASCEND trial offers 'mixed messages' on aspirin, omega-3

September 20, 2018
More »
Video
Meeting News

VIDEO: Heart failure presents unique challenges in diabetes

July 14, 2018
More »